0001453814-19-000143.txt : 20191028
0001453814-19-000143.hdr.sgml : 20191028
20191028161846
ACCESSION NUMBER: 0001453814-19-000143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191028
FILED AS OF DATE: 20191028
DATE AS OF CHANGE: 20191028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kurtz Neil M
CENTRAL INDEX KEY: 0001370350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34387
FILM NUMBER: 191173216
MAIL ADDRESS:
STREET 1: 11085 NORTH TORREY PINES ROAD, SUITE 103
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medidata Solutions, Inc.
CENTRAL INDEX KEY: 0001453814
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 522319066
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 HUDSON ST., 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 212.918.1800
MAIL ADDRESS:
STREET 1: 350 HUDSON ST., 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
wf-form4_157229385318047.xml
FORM 4
X0306
4
2019-10-28
1
0001453814
Medidata Solutions, Inc.
MDSO
0001370350
Kurtz Neil M
C/O MEDIDATA SOLUTIONS, INC.
350 HUDSON STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
Common Stock
2019-10-28
4
D
0
119161
92.25
D
0
D
On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger").
Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration").
/s/ Michael I. Otner, Attorney-in-Fact
2019-10-28